CoChat
Sign Up
Cited by 855

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Exosomes as a new frontier of cancer liquid biopsy

Yu, Dan, Li, Yixin, Wang, Maoye, Gu, Jianmei, Xu, Wenrong, Cai, Hui, Fang, Xinjian, Zhang, Xu·2022·Molecular Cancer
DOI 10.1186/s12943-022-01509-9PMC PMC8855550
Open this paper in CoChat — free account

Abstract

Liquid biopsy, characterized by minimally invasive detection through biofluids such as blood, saliva, and urine, has emerged as a revolutionary strategy for cancer diagnosis and prognosis prediction. Exosomes are a subset of extracellular vesicles (EVs) that shuttle molecular cargoes from donor cells to recipient cells and play a crucial role in mediating intercellular communication. Increasing studies suggest that exosomes have a great promise to serve as novel biomarkers in liquid biopsy, since large quantities of exosomes are enriched in body fluids and are involved in numerous physiological and pathological processes. However, the further clinical application of exosomes has been greatly restrained by the lack of high-quality separation and component analysis methods. This review aims to provide a comprehensive overview on the conventional and novel technologies for exosome isolation, characterization and content detection. Additionally, the roles of exosomes serving as potential biomarkers in liquid biopsy for the diagnosis, treatment monitoring, and prognosis prediction of cancer are summarized. Finally, the prospects and challenges of applying exosome-based liquid biopsy to precision medicine are evaluated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-022-01509-9

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Exosomes as a new target for liquid biopsy. Exosomes are enriched in body fluids and are critically involved in tumorigenesis, tumor progression and metastasis. Compared with CTC and ctDNA, exosomes show superior characteristics such as living-cell secreted vesicles, large amounts and stable circulation. Traditional and advanced technologies have been used to separate exosomes from various body fluids and to detect exosomal cargoes. The detection of specific molecules of exosome may provide a new strategy for cancer diagnosis, progression monitoring, and prognosis prediction
Fig. 1 Exosomes as a new target for liquid biopsy. Exosomes are enriched in body fluids and are critically involved in tumorigenesis, tumor progression and metastasis. Compared with CTC and ctDNA, exosomes show superior characteristics such as living-cell secreted vesicles, large amounts and stable circulation. Traditional and advanced technologies have been used to separate exosomes from various body fluids and to detect exosomal cargoes. The detection of specific molecules of exosome may provide a new strategy for cancer diagnosis, progression monitoring, and prognosis predictionCC BY · PubMed Central
Fig. 2 The biogenesis, contents, and internalization of exosomes. Exosomes are vesicles derived from the fusion of multivesicular bodies with plasma membranes. Cytoplasmic contents of donor cells such as nucleic acids and proteins are sorted into exosomes and are delivered to recipient cells through the manner of endocytosis, phagocytosis, direct fusion or direct binding (receptor-ligand interaction)
Fig. 2 The biogenesis, contents, and internalization of exosomes. Exosomes are vesicles derived from the fusion of multivesicular bodies with plasma membranes. Cytoplasmic contents of donor cells such as nucleic acids and proteins are sorted into exosomes and are delivered to recipient cells through the manner of endocytosis, phagocytosis, direct fusion or direct binding (receptor-ligand interaction)CC BY · PubMed Central
Fig. 3 New technologies for the isolation of exosomes. A Immunoaffinity/ immunomagnetic enrichment. Copyright 2020 by Yang [58], 2017 by Kang [59], 2018 by Cai [60], 2020 by Sun [61]. B Physical feature-based separation. Copyright 2017 by Liu [62], 2019 by Sunkara V [63], 2019 by Hattori [64]. C Lipid mediated-separation. Copyright 2018 by Xu [65], 2021 by Jiang [66]. D Acoustic-based isolation / Thermophoretic enrichment. Copyright 2021 by Tayebi [67], 2019 by Liu [68], 2021 by Tian [69]
Fig. 3 New technologies for the isolation of exosomes. A Immunoaffinity/ immunomagnetic enrichment. Copyright 2020 by Yang [58], 2017 by Kang [59], 2018 by Cai [60], 2020 by Sun [61]. B Physical feature-based separation. Copyright 2017 by Liu [62], 2019 by Sunkara V [63], 2019 by Hattori [64]. C Lipid mediated-separation. Copyright 2018 by Xu [65], 2021 by Jiang [66]. D Acoustic-based isolation / Thermophoretic enrichment. Copyright 2021 by Tayebi [67], 2019 by Liu [68], 2021 by Tian [69]CC BY · PubMed Central
Fig. 4 Technologies for the characterization of exosomes. A Transmission electron microscopy. Copyright 2020 by Li [99]. B Cryo-electron microscopy. Copyright 2018 by Tian [97]. C Scanning electron microscopy. Copyright 2010 by Sharma [96]. D Atomic force microscopy. Copyright 2010 by Sharma [96]. E Dynamic light scattering. F Nanoparticle Tracking Analysis. G Tunable resistive pulse sensing
Fig. 4 Technologies for the characterization of exosomes. A Transmission electron microscopy. Copyright 2020 by Li [99]. B Cryo-electron microscopy. Copyright 2018 by Tian [97]. C Scanning electron microscopy. Copyright 2010 by Sharma [96]. D Atomic force microscopy. Copyright 2010 by Sharma [96]. E Dynamic light scattering. F Nanoparticle Tracking Analysis. G Tunable resistive pulse sensingCC BY · PubMed Central
Fig. 5 New methods to detect the contents of exosomes. A Colorimetric detection. Copyright 2018 by Chen [110], 2020 by Di [112]. B Fluorescent detection. Copyright 2014 by He [36], 2018 by Jin [113]. C Electrochemical detection. Copyright 2020 by Cao [114]. 2020 by Kashefi-Kheyrabadi L [115]. D SPR/SERS detection. Copyright 2014 by Hyungsoon Im [116], 2020 by Dong [117]. E Single exosome detection. Copyright 2019 by Wang [118], 2019 by He [119]. F ddPCR. Copyright 2020 by Sun [61], 2021 by Liu [120]. G Molecular beacon., Copyright 2016 by Ji HyeLee [121], 2015 by Ji HyeLee [122]. H LSPR detection. Copyright 2021 by Wu [123]
Fig. 5 New methods to detect the contents of exosomes. A Colorimetric detection. Copyright 2018 by Chen [110], 2020 by Di [112]. B Fluorescent detection. Copyright 2014 by He [36], 2018 by Jin [113]. C Electrochemical detection. Copyright 2020 by Cao [114]. 2020 by Kashefi-Kheyrabadi L [115]. D SPR/SERS detection. Copyright 2014 by Hyungsoon Im [116], 2020 by Dong [117]. E Single exosome detection. Copyright 2019 by Wang [118], 2019 by He [119]. F ddPCR. Copyright 2020 by Sun [61], 2021 by Liu [120]. G Molecular beacon., Copyright 2016 by Ji HyeLee [121], 2015 by Ji HyeLee [122]. H LSPR detection. Copyright 2021 by Wu [123]CC BY · PubMed Central
Fig. 6 The application of exosomes in cancer liquid biopsy. Cancer-derived exosomes are enriched in differentially expressed proteins and nucleic acids, and have been tested as new biomarkers for the early diagnosis, stage classification, and prognosis prediction of different cancers, highlighting their important value in cancer liquid biopsy and precision medicine
Fig. 6 The application of exosomes in cancer liquid biopsy. Cancer-derived exosomes are enriched in differentially expressed proteins and nucleic acids, and have been tested as new biomarkers for the early diagnosis, stage classification, and prognosis prediction of different cancers, highlighting their important value in cancer liquid biopsy and precision medicineCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 201

  1. Li S, Yi M, Dong B, Tan X, Luo S, Wu K. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction. Int J Cancer. 2021;148(11):2640–51. · DOI
  2. Sala M, Ros M, Saltel F. A complex and evolutive character: two face aspects of ECM in tumor progression. Front Oncol. 2020;10:1620. · DOI
  3. Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005;17:879–87. · DOI
  4. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med. 2012;10:5. · DOI
  5. Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118:1917–50. · DOI
  6. Lin S, Yu Z, Chen D, Wang Z, Miao J, Li Q, et al. Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications. Small (Weinheim an der Bergstrasse, Germany). 2020;16:e1903916. · DOI
  7. Zhang Y-C, Zhou Q, Wu Y-L. The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer. J Hematol Oncol. 2017;10:167. · DOI
  8. Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836–48. · DOI · Paper page
  9. Kawamura S, Iinuma H, Wada K, Takahashi K, Minezaki S, Kainuma M, et al. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients. J Hepatobiliary Pancreat Sci. 2019;26:63–72. · DOI
  10. Nimir M, Ma Y, Jeffreys SA, Opperman T, Young F, Khan T, et al. Detection of AR-V7 in liquid biopsies of castrate resistant prostate cancer patients: a comparison of AR-V7 analysis in circulating tumor cells, circulating tumor RNA and exosomes. Cells. 2019;8(7):688. · DOI
  11. Cai X, Janku F, Zhan Q, Fan J-B. Accessing genetic information with liquid biopsies. Trends Genet. 2015;31:564–75. · DOI
  12. Ye Q, Ling S, Zheng S, Xu X. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Mol Cancer. 2019;18:114. · DOI
  13. Vaidyanathan R, Soon RH, Zhang P, Jiang K, Lim CT. Cancer diagnosis: from tumor to liquid biopsy and beyond. Lab Chip. 2018;19:11–34.
  14. Yu W, Hurley J, Roberts D, Chakrabortty S, Enderle D, Noerholm M, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021;32(4):466–77. · DOI
  15. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7:789–804. · DOI
  16. He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8:237–55. · DOI
  17. Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014;14:1891–900. · DOI
  18. Dobhal G, Datta A, Ayupova D, Teesdale-Spittle P, Goreham RV. Isolation, characterisation and detection of breath-derived extracellular vesicles. Sci Rep. 2020;10:17381. · DOI
  19. Patel GK, Khan MA, Zubair H, Srivastava SK, Khushman M, Singh S, et al. Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. Sci Rep. 2019;9:5335. · DOI
  20. An M, Wu J, Zhu J, Lubman DM. Comparison of an optimized ultracentrifugation method versus size-exclusion chromatography for isolation of exosomes from human serum. J Proteome Res. 2018;17:3599–605. · DOI
  21. Lobb RJ, Becker M, Wen SW, Wong CSF, Wiegmans AP, Leimgruber A, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracellular Vesicles. 2015;4:27031. · DOI
  22. Wang W, Luo J, Wang S. Recent progress in isolation and detection of extracellular vesicles for cancer diagnostics. Adv Healthc Mater. 2018;7:e1800484. · DOI
  23. Hu T, Wolfram J, Srivastava S. Extracellular vesicles in cancer detection: hopes and hypes. Trends Cancer. 2021;7(2):122–33. · DOI
  24. Shao H, Chung J, Issadore D. Diagnostic technologies for circulating tumour cells and exosomes. Biosci Rep. 2015;36:e00292. · DOI
  25. Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8:83. · DOI
  26. Hu W, Liu C, Bi Z-Y, Zhou Q, Zhang H, Li L-L, et al. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology. Mol Cancer. 2020;19:102. · DOI
  27. van Niel G, Charrin S, Simoes S, Romao M, Rochin L, Saftig P, et al. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev Cell. 2011;21:708–21. · DOI · Paper page
  28. van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213–28. · DOI · Paper page
  29. Li W, Li C, Zhou T, Liu X, Liu X, Li X, et al. Role of exosomal proteins in cancer diagnosis. Mol Cancer. 2017;16:145. · DOI
  30. Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell. 2020;182(4):1044–1061.e18. · DOI
  31. He M, Crow J, Roth M, Zeng Y, Godwin AK. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip. 2014;14:3773–80. · DOI
  32. Jakobsen KR, Paulsen BS, Bæk R, Varming K, Sorensen BS, Jørgensen MM. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J Extracellular Vesicles. 2015;4:26659. · DOI
  33. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–6. · DOI · Paper page
  34. Zhou L, Wang W, Wang F, Yang S, Hu J, Lu B, et al. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma. Mol Cancer. 2021;20:57. · DOI
  35. Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9:191. · DOI · Paper page
  36. Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63–78. · DOI
  37. Royo F, Théry C, Falcón-Pérez JM, Nieuwland R, Witwer KW. Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee. Cells. 2020;9(9):1955. · DOI
  38. Vidal M, Mangeat P, Hoekstra D. Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation. J Cell Sci. 1997;110(Pt 16):1867–77. · DOI
  39. Poliakov A, Spilman M, Dokland T, Amling CL, Mobley JA. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate. 2009;69:159–67. · DOI
  40. Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods (San Diego, Calif). 2015;87:3–10. · DOI
  41. Haraszti RA, Miller R, Stoppato M, Sere YY, Coles A, Didiot M-C, et al. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol Ther. 2018;26:2838–47. · DOI · Paper page
  42. Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82:1024–32. · DOI
  43. Böing AN, van der Pol E, Grootemaat AE, Coumans FAW, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracellular Vesicles. 2014;3. · DOI
  44. Guo J, Wu C, Lin X, Zhou J, Zhang J, Zheng W, et al. Establishment of a simplified dichotomic size-exclusion chromatography for isolating extracellular vesicles toward clinical applications. J Extracellular Vesicles. 2021;10:e12145. · DOI
  45. Monguió-Tortajada M, Gálvez-Montón C, Bayes-Genis A, Roura S, Borràs FE. Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography. Cell Mol Life Sci. 2019;76:2369–82. · DOI
  46. Wei R, Zhao L, Kong G, Liu X, Zhu S, Zhang S, et al. Combination of size-exclusion chromatography and ultracentrifugation improves the proteomic profiling of plasma-derived small extracellular vesicles. Biol Proced Online. 2020;22:12. · DOI
  47. Weng Y, Sui Z, Shan Y, Hu Y, Chen Y, Zhang L, et al. Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling. Analyst. 2016;141:4640–6. · DOI
  48. Rider MA, Hurwitz SN, Meckes DG. ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci Rep. 2016;6:23978. · DOI
  49. Ding M, Wang C, Lu X, Zhang C, Zhou Z, Chen X, et al. Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling. Anal Bioanal Chem. 2018;410:3805–14. · DOI
  50. Lin B, Tian T, Lu Y, Liu D, Huang M, Zhu L, et al. Tracing tumor-derived exosomal PD-L1 by dual-aptamer activated proximity-induced droplet digital PCR. Angewandte Chemie (International ed in English). 2021;60:7582–6. · DOI
  51. Yang Q, Cheng L, Hu L, Lou D, Zhang T, Li J, et al. An integrative microfluidic device for isolation and ultrasensitive detection of lung cancer-specific exosomes from patient urine. Biosens Bioelectron. 2020;163:112290. · DOI
  52. Kang Y-T, Kim YJ, Bu J, Cho Y-H, Han S-W, Moon B-I. High-purity capture and release of circulating exosomes using an exosome-specific dual-patterned immunofiltration (ExoDIF) device. Nanoscale. 2017;9:13495–505. · DOI
  53. Cai S, Luo B, Jiang P, Zhou X, Lan F, Yi Q, et al. Immuno-modified superparamagnetic nanoparticles via host-guest interactions for high-purity capture and mild release of exosomes. Nanoscale. 2018;10:14280–9. · DOI
  54. Sun N, Lee Y-T, Zhang RY, Kao R, Teng P-C, Yang Y, et al. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring. Nat Commun. 2020;11:4489. · DOI
  55. Liu F, Vermesh O, Mani V, Ge TJ, Madsen SJ, Sabour A, et al. The exosome total isolation chip. ACS Nano. 2017;11:10712–23. · DOI
  56. Sunkara V, Kim C-J, Park J, Woo H-K, Kim D, Ha HK, et al. Fully automated, label-free isolation of extracellular vesicles from whole blood for cancer diagnosis and monitoring. Theranostics. 2019;9:1851–63. · DOI
  57. Margolis E, Brown G, Partin A, Carter B, McKiernan J, Tutrone R, et al. Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) prostate Intelliscore test in three independent prospective studies. Prostate Cancer Prostatic Dis. 2021. https://doi.org/10.1038/s41391-021-00456-8. · DOI
  58. Xu H, Liao C, Zuo P, Liu Z, Ye B-C. Magnetic-based microfluidic device for on-chip isolation and detection of tumor-derived exosomes. Anal Chem. 2018;90:13451–8. · DOI
  59. Jiang S, Li Q, Wang C, Pang Y, Sun Z, Xiao R. In Situ Exosomal MicroRNA determination by target-triggered SERS and FeO@TiO-based exosome accumulation. ACS Sensors. 2021;6:852–62. · DOI
  60. Tayebi M, Yang D, Collins DJ, Ai Y. Deterministic sorting of submicrometer particles and extracellular vesicles using a combined electric and acoustic field. Nano Lett. 2021;21:6835–42. · DOI
  61. Liu C, Zhao J, Tian F, Cai L, Zhang W, Feng Q, et al. Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers. Nat Biomed Eng. 2019;3:183–93. · DOI
  62. Tian F, Zhang S, Liu C, Han Z, Liu Y, Deng J, et al. Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer. Nat Commun. 2021;12:2536. · DOI
  63. Zhang P, He M, Zeng Y. Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating. Lab Chip. 2016;16:3033–42. · DOI
  64. Fang S, Tian H, Li X, Jin D, Li X, Kong J, et al. Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS One. 2017;12:e0175050. · DOI
  65. Chen J, Xu Y, Lu Y, Xing W. Isolation and visible detection of tumor-derived exosomes from plasma. Anal Chem. 2018;90:14207–15. · DOI
  66. Wang Y, Li Q, Shi H, Tang K, Qiao L, Yu G, et al. Microfluidic Raman biochip detection of exosomes: a promising tool for prostate cancer diagnosis. Lab Chip. 2020;20:4632–7. · DOI
  67. Zhao Z, Yang Y, Zeng Y, He M. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip. 2016;16:489–96. · DOI
  68. Wunsch BH, Smith JT, Gifford SM, Wang C, Brink M, Bruce RL, et al. Nanoscale lateral displacement arrays for the separation of exosomes and colloids down to 20 nm. Nat Nanotechnol. 2016;11:936–40. · DOI
  69. Liang L-G, Kong M-Q, Zhou S, Sheng Y-F, Wang P, Yu T, et al. An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer. Sci Rep. 2017;7:46224. · DOI
  70. Davies RT, Kim J, Jang SC, Choi E-J, Gho YS, Park J. Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip. 2012;12:5202–10. · DOI
  71. Hattori Y, Shimada T, Yasui T, Kaji N, Baba Y. Micro- and nanopillar chips for continuous separation of extracellular vesicles. Anal Chem. 2019;91:6514–21. · DOI
  72. Dong L, Zieren RC, Horie K, Kim C-J, Mallick E, Jing Y, et al. Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium. J Extracellular Vesicles. 2020;10:e12044. · DOI
  73. Wan Y, Cheng G, Liu X, Hao S-J, Nisic M, Zhu C-D, et al. Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nat Biomed Eng. 2017;1:0058. · DOI
  74. Lee K, Shao H, Weissleder R, Lee H. Acoustic purification of extracellular microvesicles. ACS Nano. 2015;9:2321–7. · DOI
  75. Kang Y-T, Hadlock T, Jolly S, Nagrath S. Extracellular vesicles on demand (EVOD) chip for screening and quantification of cancer-associated extracellular vesicles. Biosens Bioelectron. 2020;168:112535. · DOI
  76. Li B, Pan W, Liu C, Guo J, Shen J, Feng J, et al. Homogenous magneto-fluorescent nanosensor for tumor-derived exosome isolation and analysis. ACS Sensors. 2020;5:2052–60. · DOI
  77. Rho J, Chung J, Im H, Liong M, Shao H, Castro CM, et al. Magnetic nanosensor for detection and profiling of erythrocyte-derived microvesicles. ACS Nano. 2013;7:11227–33. · DOI
  78. Chen Y, Zhu Q, Cheng L, Wang Y, Li M, Yang Q, et al. Exosome detection via the ultrafast-isolation system: EXODUS. Nat Methods. 2021;18:212–8. · DOI
  79. Wan Y, Maurer M, He H-Z, Xia Y-Q, Hao S-J, Zhang W-L, et al. Enrichment of extracellular vesicles with lipid nanoprobe functionalized nanostructured silica. Lab Chip. 2019;19:2346–55. · DOI
  80. Kang Y-T, Purcell E, Palacios-Rolston C, Lo T-W, Ramnath N, Jolly S, et al. Isolation and profiling of circulating tumor-associated exosomes using extracellular vesicular lipid-protein binding affinity based microfluidic device. Small (Weinheim an der Bergstrasse, Germany). 2019;15:e1903600. · DOI
  81. Nakai W, Yoshida T, Diez D, Miyatake Y, Nishibu T, Imawaka N, et al. A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep. 2016;6:33935. · DOI
  82. Pang Y, Shi J, Yang X, Wang C, Sun Z, Xiao R. Personalized detection of circling exosomal PD-L1 based on FeO@TiO isolation and SERS immunoassay. Biosens Bioelectron. 2020;148:111800. · DOI
  83. Ku A, Lim HC, Evander M, Lilja H, Laurell T, Scheding S, et al. Acoustic enrichment of extracellular vesicles from biological fluids. Anal Chem. 2018;90:8011–9. · DOI
  84. Wu M, Ouyang Y, Wang Z, Zhang R, Huang P-H, Chen C, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A. 2017;114:10584–9. · DOI
  85. Gu Y, Chen C, Mao Z, Bachman H, Becker R, Rufo J, et al. Acoustofluidic centrifuge for nanoparticle enrichment and separation. Sci Adv. 2021;7(1):eabc0467. · DOI
  86. Gardiner C, Di Vizio D, Sahoo S, Théry C, Witwer KW, Wauben M, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracellular Vesicles. 2016;5:32945. · DOI
  87. Sharma S, Rasool HI, Palanisamy V, Mathisen C, Schmidt M, Wong DT, et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano. 2010;4:1921–6. · DOI
  88. Tian Y, Ma L, Gong M, Su G, Zhu S, Zhang W, et al. Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry. ACS Nano. 2018;12:671–80. · DOI
  89. Sharma S, Gillespie BM, Palanisamy V, Gimzewski JK. Quantitative nanostructural and single-molecule force spectroscopy biomolecular analysis of human-saliva-derived exosomes. Langmuir. 2011;27:14394–400. · DOI
  90. Li B, Liu C, Pan W, Shen J, Guo J, Luo T, et al. Facile fluorescent aptasensor using aggregation-induced emission luminogens for exosomal proteins profiling towards liquid biopsy. Biosens Bioelectron. 2020;168:112520. · DOI
  91. Street JM, Koritzinsky EH, Glispie DM, Star RA, Yuen PST. Urine exosomes: an emerging trove of biomarkers. Adv Clin Chem. 2017;78:103–22. · DOI
  92. Carnino JM, Lee H, Jin Y. Isolation and characterization of extracellular vesicles from Broncho-alveolar lavage fluid: a review and comparison of different methods. Respir Res. 2019;20:240. · DOI
  93. Kurian TK, Banik S, Gopal D, Chakrabarti S, Mazumder N. Elucidating methods for isolation and quantification of exosomes: a review. Mol Biotechnol. 2021;63:249–66. · DOI
  94. Božič D, Sitar S, Junkar I, Štukelj R, Pajnič M, Žagar E, et al. Viscosity of plasma as a key factor in assessment of extracellular vesicles by light scattering. Cells. 2019;8(9):1046. · DOI
  95. Bachurski D, Schuldner M, Nguyen P-H, Malz A, Reiners KS, Grenzi PC, et al. Extracellular vesicle measurements with nanoparticle tracking analysis - An accuracy and repeatability comparison between NanoSight NS300 and ZetaView. J Extracellular Vesicles. 2019;8:1596016. · DOI
  96. Coumans FAW, van der Pol E, Böing AN, Hajji N, Sturk G, van Leeuwen TG, et al. Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing. J Extracellular Vesicles. 2014;3:25922. · DOI
  97. Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell. 2019;177(2):428–445.e18. · DOI · Paper page
  98. Ueda K, Ishikawa N, Tatsuguchi A, Saichi N, Fujii R, Nakagawa H. Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes. Sci Rep. 2014;4:6232. · DOI
  99. Yokoyama S, Takeuchi A, Yamaguchi S, Mitani Y, Watanabe T, Matsuda K, et al. Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-measurement by ELISA. PLoS One. 2017;12:e0183337. · DOI
  100. Xia Y, Liu M, Wang L, Yan A, He W, Chen M, et al. A visible and colorimetric aptasensor based on DNA-capped single-walled carbon nanotubes for detection of exosomes. Biosens Bioelectron. 2017;92:8–15. · DOI
  101. Chen Z, Cheng S-B, Cao P, Qiu Q-F, Chen Y, Xie M, et al. Detection of exosomes by ZnO nanowires coated three-dimensional scaffold chip device. Biosens Bioelectron. 2018;122:211–6. · DOI
  102. Di H, Mi Z, Sun Y, Liu X, Liu X, Li A, et al. Nanozyme-assisted sensitive profiling of exosomal proteins for rapid cancer diagnosis. Theranostics. 2020;10:9303–14. · DOI
  103. Jin D, Yang F, Zhang Y, Liu L, Zhou Y, Wang F, et al. ExoAPP: exosome-oriented, aptamer nanoprobe-enabled surface proteins profiling and detection. Anal Chem. 2018;90:14402–11. · DOI
  104. Cao Y, Wang Y, Yu X, Jiang X, Li G, Zhao J. Identification of programmed death ligand-1 positive exosomes in breast cancer based on DNA amplification-responsive metal-organic frameworks. Biosens Bioelectron. 2020;166:112452. · DOI
  105. Kashefi-Kheyrabadi L, Kim J, Chakravarty S, Park S, Gwak H, Kim S-I, et al. Detachable microfluidic device implemented with electrochemical aptasensor (DeMEA) for sequential analysis of cancerous exosomes. Biosens Bioelectron. 2020;169:112622. · DOI
  106. Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014;32:490–5. · DOI
  107. Dong S, Wang Y, Liu Z, Zhang W, Yi K, Zhang X, et al. Beehive-inspired macroporous SERS probe for cancer detection through capturing and analyzing exosomes in plasma. ACS Appl Mater Interfaces. 2020;12:5136–46. · DOI
  108. Wang H, Jiang D, Li W, Xiang X, Zhao J, Yu B, et al. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma. Theranostics. 2019;9:5347–58. · DOI
  109. He D, Wang H, Ho S-L, Chan H-N, Hai L, He X, et al. Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring. Theranostics. 2019;9:4494–507. · DOI
  110. Liu C, Li B, Lin H, Yang C, Guo J, Cui B, et al. Multiplexed analysis of small extracellular vesicle-derived mRNAs by droplet digital PCR and machine learning improves breast cancer diagnosis. Biosens Bioelectron. 2021;194:113615. · DOI
  111. Lee JH, Kim JA, Jeong S, Rhee WJ. Simultaneous and multiplexed detection of exosome microRNAs using molecular beacons. Biosens Bioelectron. 2016;86:202–10. · DOI
  112. Lee JH, Kim JA, Kwon MH, Kang JY, Rhee WJ. In situ single step detection of exosome microRNA using molecular beacon. Biomaterials. 2015;54:116–25. · DOI
  113. Wu W, Yu X, Wu J, Wu T, Fan Y, Chen W, et al. Surface plasmon resonance imaging-based biosensor for multiplex and ultrasensitive detection of NSCLC-associated exosomal miRNAs using DNA programmed heterostructure of Au-on-Ag. Biosens Bioelectron. 2021;175:112835. · DOI
  114. Liu C, Xu X, Li B, Situ B, Pan W, Hu Y, et al. Single-exosome-counting immunoassays for cancer diagnostics. Nano Lett. 2018;18:4226–32. · DOI
  115. Wei P, Wu F, Kang B, Sun X, Heskia F, Pachot A, et al. Plasma extracellular vesicles detected by single molecule array technology as a liquid biopsy for colorectal cancer. J Extracellular Vesicles. 2020;9:1809765. · DOI
  116. Yu X, He L, Pentok M, Yang H, Yang Y, Li Z, et al. An aptamer-based new method for competitive fluorescence detection of exosomes. Nanoscale. 2019;11:15589–95. · DOI
  117. Zhou Y-G, Mohamadi RM, Poudineh M, Kermanshah L, Ahmed S, Safaei TS, et al. Interrogating circulating microsomes and exosomes using metal nanoparticles. Small (Weinheim an der Bergstrasse, Germany). 2016;12:727–32. · DOI
  118. Jeong S, Park J, Pathania D, Castro CM, Weissleder R, Lee H. Integrated magneto-electrochemical sensor for exosome analysis. ACS Nano. 2016;10:1802–9. · DOI
  119. Park J, Park JS, Huang C-H, Jo A, Cook K, Wang R, et al. An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma. Nat Biomed Eng. 2021;5:678–89. · DOI
  120. Homola J. Surface plasmon resonance sensors for detection of chemical and biological species. Chem Rev. 2008;108:462–93. · DOI
  121. Zeng S, Baillargeat D, Ho H-P, Yong K-T. Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications. Chem Soc Rev. 2014;43:3426–52. · DOI
  122. Liu C, Zeng X, An Z, Yang Y, Eisenbaum M, Gu X, et al. Sensitive detection of exosomal proteins via a compact surface plasmon resonance biosensor for cancer diagnosis. ACS Sensors. 2018;3:1471–9. · DOI
  123. Kneipp, Wang, Kneipp, Itzkan, Dasari, Feld. Population pumping of excited vibrational states by spontaneous surface-enhanced Raman scattering. Phys Rev Lett. 1996;76:2444–7. · DOI
  124. Kwizera EA, O'Connor R, Vinduska V, Williams M, Butch ER, Snyder SE, et al. Molecular detection and analysis of exosomes using surface-enhanced Raman scattering gold nanorods and a miniaturized device. Theranostics. 2018;8:2722–38. · DOI
  125. Zhao X, Zhang W, Qiu X, Mei Q, Luo Y, Fu W. Rapid and sensitive exosome detection with CRISPR/Cas12a. Anal Bioanal Chem. 2020;412:601–9. · DOI
  126. Xing S, Lu Z, Huang Q, Li H, Wang Y, Lai Y, et al. An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification. Theranostics. 2020;10:10262–73. · DOI
  127. Li H, Xing S, Xu J, He Y, Lai Y, Wang Y, et al. Aptamer-based CRISPR/Cas12a assay for the ultrasensitive detection of extracellular vesicle proteins. Talanta. 2021;221:121670. · DOI
  128. Guo K, Li Z, Win A, Coreas R, Adkins GB, Cui X, et al. Calibration-free analysis of surface proteins on single extracellular vesicles enabled by DNA nanostructure. Biosens Bioelectron. 2021;192:113502. · DOI
  129. Liu C, Zhao J, Tian F, Chang J, Zhang W, Sun J. λ-DNA- and aptamer-mediated sorting and analysis of extracellular vesicles. J Am Chem Soc. 2019;141:3817–21. · DOI
  130. Li W, Shao B, Liu C, Wang H, Zheng W, Kong W, et al. Liquid biospy: noninvasive diagnosis and molecular phenotyping of breast cancer through microbead-assisted flow cytometry detection of tumor-derived extracellular vesicles (small methods 11/2018). Small Methods. 2018;2:1800050. · DOI
  131. Liu H, Yuan W, Pang Q, Xue C, Yan X. Single-particle analysis of tear fluid reveals abundant presence of tissue factor-exposing extracellular vesicles with strong coagulation activity. Talanta. 2021;239:123089. · DOI
  132. Tan S, Xia L, Yi P, Han Y, Tang L, Pan Q, et al. Exosomal miRNAs in tumor microenvironment. J Exp Clin Cancer Res. 2020;39:67. · DOI
  133. Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang W, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18:116. · DOI
  134. Gandham S, Su X, Wood J, Nocera AL, Alli SC, Milane L, et al. Technologies and standardization in research on extracellular vesicles. Trends Biotechnol. 2020;38:1066–98. · DOI
  135. Mateescu B, Kowal EJK, van Balkom BWM, Bartel S, Bhattacharyya SN, Buzás EI, et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper. J Extracellular Vesicles. 2017;6:1286095. · DOI
  136. Jaluria P, Konstantopoulos K, Betenbaugh M, Shiloach J. A perspective on microarrays: current applications, pitfalls, and potential uses. Microb Cell Factories. 2007;6:4. · DOI
  137. Boriachek K, Masud MK, Palma C, Phan H-P, Yamauchi Y, Hossain MSA, et al. Avoiding pre-isolation step in exosome analysis: direct isolation and sensitive detection of exosomes using gold-loaded nanoporous ferric oxide nanozymes. Anal Chem. 2019;91:3827–34. · DOI
  138. Zhang P, Zhou X, Zeng Y. Multiplexed immunophenotyping of circulating exosomes on nano-engineered ExoProfile chip towards early diagnosis of cancer. Chem Sci. 2019;10:5495–504. · DOI
  139. Tayebi M, Zhou Y, Tripathi P, Chandramohanadas R, Ai Y. Exosome purification and analysis using a facile microfluidic hydrodynamic trapping device. Anal Chem. 2020;92:10733–42. · DOI
  140. Cho S, Yang HC, Rhee WJ. Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis. Biosens Bioelectron. 2019;146:111749. · DOI
  141. Zhang Z, Tang C, Zhao L, Xu L, Zhou W, Dong Z, et al. Aptamer-based fluorescence polarization assay for separation-free exosome quantification. Nanoscale. 2019;11:10106–13. · DOI
  142. Tayebi M, Tavakkoli Yaraki M, Yang HY, Ai Y. A MoS2–MWCNT based fluorometric nanosensor for exosome detection and quantification. Nanoscale Adv. 2019;1:2866–72. · DOI
  143. Wang S, Zhang L, Wan S, Cansiz S, Cui C, Liu Y, et al. Aptasensor with expanded nucleotide using DNA nanotetrahedra for electrochemical detection of cancerous exosomes. ACS Nano. 2017;11:3943–9. · DOI
  144. Dong H, Chen H, Jiang J, Zhang H, Cai C, Shen Q. Highly sensitive electrochemical detection of tumor exosomes based on aptamer recognition-induced multi-DNA release and cyclic enzymatic amplification. Anal Chem. 2018;90:4507–13. · DOI
  145. Huang R, He L, Xia Y, Xu H, Liu C, Xie H, et al. A sensitive Aptasensor based on a hemin/G-Quadruplex-assisted signal amplification strategy for electrochemical detection of gastric cancer exosomes. Small (Weinheim an der Bergstrasse, Germany). 2019;15:e1900735. · DOI
  146. Zhu L, Wang K, Cui J, Liu H, Bu X, Ma H, et al. Label-free quantitative detection of tumor-derived exosomes through surface plasmon resonance imaging. Anal Chem. 2014;86:8857–64. · DOI
  147. Wang Q, Zou L, Yang X, Liu X, Nie W, Zheng Y, et al. Direct quantification of cancerous exosomes via surface plasmon resonance with dual gold nanoparticle-assisted signal amplification. Biosens Bioelectron. 2019;135:129–36. · DOI
  148. Fan Y, Duan X, Zhao M, Wei X, Wu J, Chen W, et al. High-sensitive and multiplex biosensing assay of NSCLC-derived exosomes via different recognition sites based on SPRi array. Biosens Bioelectron. 2020;154:112066. · DOI
  149. Sina AAI, Vaidyanathan R, Wuethrich A, Carrascosa LG, Trau M. Label-free detection of exosomes using a surface plasmon resonance biosensor. Anal Bioanal Chem. 2019;411:1311–8. · DOI
  150. Thakur A, Xu C, Li WK, Qiu G, He B, Ng S-P, et al. In vivo liquid biopsy for glioblastoma malignancy by the AFM and LSPR based sensing of exosomal CD44 and CD133 in a mouse model. Biosens Bioelectron. 2021;191:113476. · DOI
  151. Shin H, Oh S, Hong S, Kang M, Kang D, Ji Y-G, et al. Early-stage lung cancer diagnosis by deep learning-based spectroscopic analysis of circulating exosomes. ACS Nano. 2020;14:5435–44. · DOI
  152. Wang C, Ding Q, Plant P, Basheer M, Yang C, Tawedrous E, et al. Droplet digital PCR improves urinary exosomal miRNA detection compared to real-time PCR. Clin Biochem. 2019;67:54–9. · DOI
  153. Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, et al. BEAMing and droplet digital PCR analysis of mutant IDH1 mRNA in glioma patient serum and cerebrospinal fluid extracellular vesicles. Mol Ther Nucleic Acids. 2013;2:e109. · DOI
  154. Zhang P, Zhou X, He M, Shang Y, Tetlow AL, Godwin AK, et al. Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip. Nat Biomed Eng. 2019;3:438–51. · DOI
  155. Bai Y, Qu Y, Wu Z, Ren Y, Cheng Z, Lu Y, et al. Absolute quantification and analysis of extracellular vesicle lncRNAs from the peripheral blood of patients with lung cancer based on multi-colour fluorescence chip-based digital PCR. Biosens Bioelectron. 2019;142:111523. · DOI
  156. Stella M, Falzone L, Caponnetto A, Gattuso G, Barbagallo C, Battaglia R, et al. Serum extracellular vesicle-derived circHIPK3 and circSMARCA5 are two novel diagnostic biomarkers for glioblastoma multiforme. Pharmaceuticals (Basel, Switzerland). 2021;14(7):618. · DOI
  157. Lee J, Kwon MH, Kim JA, Rhee WJ. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer. Artif Cells Nanomed Biotechnol. 2018;46:S52–63. · DOI
  158. Chen Y, Zhai L-Y, Zhang L-M, Ma X-S, Liu Z, Li M-M, et al. Breast cancer plasma biopsy by in situ determination of exosomal microRNA-1246 with a molecular beacon. Analyst. 2021;146:2264–76. · DOI
  159. Oliveira GP, Zigon E, Rogers G, Davodian D, Lu S, Jovanovic-Talisman T, et al. Detection of extracellular vesicle RNA using molecular beacons. iScience. 2020;23:100782. · DOI
  160. Chen X, Jia M, Liu L, Qiu X, Zhang H, Yu X, et al. High-fidelity determination and tracing of small extracellular vesicle cargoes. Small (Weinheim an der Bergstrasse, Germany). 2020;16:e2002800. · DOI
  161. Zhang Y, Zhang X, Situ B, Wu Y, Luo S, Zheng L, et al. Rapid electrochemical biosensor for sensitive profiling of exosomal microRNA based on multifunctional DNA tetrahedron assisted catalytic hairpin assembly. Biosens Bioelectron. 2021;183:113205. · DOI
  162. Joshi GK, Deitz-McElyea S, Liyanage T, Lawrence K, Mali S, Sardar R, et al. Label-free Nanoplasmonic-based short noncoding RNA sensing at Attomolar concentrations allows for quantitative and highly specific assay of MicroRNA-10b in biological fluids and circulating exosomes. ACS Nano. 2015;9:11075–89. · DOI
  163. Thakur A, Qiu G, Ng S-P, Guan J, Yue J, Lee Y, et al. Direct detection of two different tumor-derived extracellular vesicles by SAM-AuNIs LSPR biosensor. Biosens Bioelectron. 2017;94:400–7. · DOI
  164. Zhao J, Liu C, Li Y, Ma Y, Deng J, Li L, et al. Thermophoretic detection of exosomal microRNAs by nanoflares. J Am Chem Soc. 2020;142:4996–5001. · DOI
  165. Wang R, Zhao X, Chen X, Qiu X, Qing G, Zhang H, et al. Rolling circular amplification (RCA)-assisted CRISPR/Cas9 cleavage (RACE) for highly specific detection of multiple extracellular vesicle MicroRNAs. Anal Chem. 2020;92:2176–85. · DOI
  166. Olmedillas-López S, García-Arranz M, García-Olmo D. Current and emerging applications of droplet digital PCR in oncology. Mol Diagn Ther. 2017;21:493–510. · DOI
  167. Shen X, Yang Y, Chen Y, Zhou C, Zhao X, Li N, et al. Evaluation of EpCAM-specific exosomal lncRNAs as potential diagnostic biomarkers for lung cancer using droplet digital PCR. J Mol Med (Berlin, Germany). 2022;100(1):87–100. · DOI
  168. Rhee WJ, Jeong S. Extracellular vesicle miRNA detection using molecular beacons. Methods Mol Biol (Clifton, NJ). 2017;1660:287–94. · DOI
  169. Ozhalici-Unal H, Armitage BA. Fluorescent DNA nanotags based on a self-assembled DNA tetrahedron. ACS Nano. 2009;3:425–33. · DOI
  170. Gao J, Zhang H, Wang Z. A DNA tetrahedron nanoprobe-based fluorescence resonance energy transfer sensing platform for intracellular tumor-related miRNA detection. Analyst. 2020;145:3535–42. · DOI
  171. Han Z, Wan F, Deng J, Zhao J, Sun J. Ultrasensitive detection of mRNA in extracellular vesicles using DNA tetrahedron-based thermophoretic assay. Nano Today. 2021;38:101203. · DOI
  172. Feng W, Newbigging AM, Tao J, Cao Y, Peng H, Le C, et al. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules. Chem Sci. 2021;12:4683–98. · DOI
  173. Duan J, Lu G, Xie Z, Lou M, Luo J, Guo L, et al. Genome-wide identification of CRISPR/Cas9 off-targets in human genome. Cell Res. 2014;24:1009–12. · DOI · Paper page
  174. Kawakami E, Tabata J, Yanaihara N, Ishikawa T, Koseki K, Iida Y, et al. Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian Cancer based on blood biomarkers. Clin Cancer Res. 2019;25:3006–15. · DOI
  175. Wu N, Zhang X-Y, Xia J, Li X, Yang T, Wang J-H. Ratiometric 3D DNA machine combined with machine learning algorithm for ultrasensitive and high-precision screening of early urinary diseases. ACS Nano. 2021;15(12):19522–34. · DOI
  176. Lee YR, Kim G, Tak WY, Jang SY, Kweon YO, Park JG, et al. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. Int J Cancer. 2019;144:1444–52. · DOI
  177. Vasconcelos MH, Caires HR, Ābols A, Xavier CPR, Linē A. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug Resist Updates. 2019;47:100647. · DOI
  178. Zhao R, Zhang Y, Zhang X, Yang Y, Zheng X, Li X, et al. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer. Mol Cancer. 2018;17:68. · DOI
  179. Wei S, Peng L, Yang J, Sang H, Jin D, Li X, et al. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer. J Exp Clin Cancer Res. 2020;39:32. · DOI
  180. Cao L-Q, Yang X-W, Chen Y-B, Zhang D-W, Jiang X-F, Xue P. Correction to: Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth. Mol Cancer. 2020;19:59. · DOI
  181. Nakano T, Chen IH, Wang C-C, Chen P-J, Tseng H-P, Huang K-T, et al. Circulating exosomal miR-92b: its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2019;19:3250–62. · DOI
  182. Pang Y, Wang C, Lu L, Wang C, Sun Z, Xiao R. Dual-SERS biosensor for one-step detection of microRNAs in exosome and residual plasma of blood samples for diagnosing pancreatic cancer. Biosens Bioelectron. 2019;130:204–13. · DOI
  183. Lewis JM, Vyas AD, Qiu Y, Messer KS, White R, Heller MJ. Integrated analysis of exosomal protein biomarkers on alternating current electrokinetic chips enables rapid detection of pancreatic cancer in patient blood. ACS Nano. 2018;12:3311–20. · DOI
  184. Carmicheal J, Hayashi C, Huang X, Liu L, Lu Y, Krasnoslobodtsev A, et al. Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer. Nanomedicine. 2019;16:88–96. · DOI
  185. Li T-D, Zhang R, Chen H, Huang Z-P, Ye X, Wang H, et al. An ultrasensitive polydopamine bi-functionalized SERS immunoassay for exosome-based diagnosis and classification of pancreatic cancer. Chem Sci. 2018;9:5372–82. · DOI
  186. Pan B, Qin J, Liu X, He B, Wang X, Pan Y, et al. Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer. Front Genet. 2019;10:1096. · DOI
  187. Ma D, Huang C, Zheng J, Tang J, Li J, Yang J, et al. Quantitative detection of exosomal microRNA extracted from human blood based on surface-enhanced Raman scattering. Biosens Bioelectron. 2018;101:167–73. · DOI
  188. Li Y, Deng J, Han Z, Liu C, Tian F, Xu R, et al. Molecular identification of tumor-derived extracellular vesicles using thermophoresis-mediated DNA computation. J Am Chem Soc. 2021;143:1290–5. · DOI
  189. Lu F, Pan S, Qi Y, Li X, Wang J. The clinical application value of RDW, CA153, and MPV in breast cancer. Clin Lab. 2021;67(2). · DOI
  190. Lee JU, Kim WH, Lee HS, Park KH, Sim SJ. Quantitative and specific detection of exosomal miRNAs for accurate diagnosis of breast cancer using a surface-enhanced Raman scattering sensor based on plasmonic head-flocked gold nanopillars. Small (Weinheim an der Bergstrasse, Germany). 2019;15:e1804968. · DOI
  191. Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, et al. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol Cancer. 2017;16:156. · DOI
  192. Zhou C, Chen Y, He X, Zheng Z, Xue D. Functional implication of exosomal miR-217 and miR-23b-3p in the progression of prostate cancer. Onco Targets Ther. 2020;13:11595–606. · DOI
  193. Li S, Zhao Y, Chen W, Yin L, Zhu J, Zhang H, et al. Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer. J Cancer. 2018;9:2659–65. · DOI
  194. Zhu S, Ni Y, Sun G, Wang Z, Chen J, Zhang X, et al. Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: association with patient outcome under abiraterone. Cancer Med. 2021;10(18):6282–90. · DOI
  195. Liu J, Yoo J, Ho JY, Jung Y, Lee S, Hur SY, et al. Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer. J Ovarian Res. 2021;14:59. · DOI
  196. Zhu Y, Wang S, Xi X, Zhang M, Liu X, Tang W, et al. Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer. Theranostics. 2021;11:181–93. · DOI
  197. Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, et al. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011;17:5812–21. · DOI
  198. Han L, Shi W-J, Xie Y-B, Zhang Z-G. Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer. World J Gastrointest Oncol. 2021;13:970–9. · DOI
  199. Aidoo-Brown J, Moschou D, Estrela P. Multiplexed prostate cancer companion diagnostic devices. Sensors (Basel, Switzerland). 2021;21(15):5023. · DOI
  200. McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol. 2016;2:882–9. · DOI

200 of 201 shown

Cited by

Sorted by citations

Metadata

Authors
Yu, D., Li, Y., Wang, M., Gu, J., Xu, W., Cai, H., Fang, X., & Zhang, X.
Venue
Molecular Cancer
Publisher
Springer Science and Business Media LLC
Published
2022-02-18
Volume
21
Issue
1
ISSN
1476-4598
DOI
10.1186/s12943-022-01509-9
PMC
PMC8855550
Cited by
855
References
11
Language
en
Licence
Funders
  • National Natural Science Foundation of China (81972310)
  • Distinguished Young Scholar Project of Jiangsu Province (BK20200043)
  • Major Natural Science Research Project for Universities in Jiangsu Province (18KJA320001)
  • Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province (2019GSZDSYS01, 2019GSZDSYS02)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review